Industry

Valbiotis Presents Additional Positive Results from the HEART Clinical Study on TOTUM•070 for Hypercholesterolemia

TOTUM•070 demonstrates excellent results in volunteers with blood LDL cholesterol levels above 130 mg/dl at randomization, its commercially targeted population and the primary subpopulation of the HEART study: Increased and lasting efficacy on blood LDL cholesterol levels, with a reduction of 13.7% after three months and 14.3% after six months, compared to placebo. A very … [Read more…]

Poxel Announces PXL770 Granted Orphan Drug Designation from the U.S. FDA for Autosomal-Dominant Polycystic Kidney Disease (ADPKD)

Completion of preclinical studies support potential to advance PXL770 into Phase 2 development for ADPKD Compelling preclinical efficacy data confirm strategic focus for PXL770 in rare metabolic diseases LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext : POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis … [Read more…]

LEO Pharma Launches AD Days Around the World Campaign to Raise Awareness of the Impact of Atopic Dermatitis Across Cultures

In partnership with Global patient advocate Ashley Ann Lora, AD Days Around the World explores the impact of atopic dermatitis (AD) on the lives of individuals around the world living with this chronic and debilitating skin disease The campaign features the emotional journey of four patient advocates from France, Italy, Germany and Spain and showcases … [Read more…]

Future Markets Research Releases Commentary on NurExone Biologic Inc, An Emerging Leader in The Exosomal Treatment of Spinal Cord Injury

LONDON–(BUSINESS WIRE)–$NRX.CN #Biostocks–The Future Markets Research Tank (FMRT) is proud to release market commentary on NurExone Biologic (TSXV: NRX) (FSE: J90), an innovative biotechnology company poised to disrupt the spinal cord injury treatment industry and the exosome research landscape. To read the full report click here, or follow the link: https://bit.ly/3UW9TzC Key Insights: Each year, … [Read more…]

New Data Reveal Molecular Drivers of Thyroid Eye Disease (TED) May Remain Activated In Patients with Low Clinical Activity Score (CAS)

— Oral presentation at AAO 2022 suggests IGF-1 and its related pathways are extensively upregulated throughout all stages of TED — DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new data defining molecular patterns in TED and further implicating the role of insulin-like growth factor-1 (IGF-1) in patients with low CAS. These … [Read more…]

UnitedHealthcare’s 2023 Medicare Plans Add New Benefits, Simplicity for Consumers

95% of all individual Medicare Advantage members will see improved benefits in 2023 Simplified comprehensive dental benefit offers broader coverage and lower costs New plan features address social determinants of health, whole-person health National UnitedHealthcare UCard™ rollout will simplify the member experience MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare® today introduced its 2023 Medicare Advantage and prescription drug plans, … [Read more…]

Humana significantly expands Medicare Advantage health plan offerings in 2023 with focus on greater value for members

$0 premiums, dental and Rx benefit enhancements, new allowances, a USAA co-branded plan, and simplified access to prescriptions offer more options for beneficiaries LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) today released details of its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2023 – with a clear focus on benefits and support based on … [Read more…]

Rare Disease PTEN Hamartoma Tumour Syndrome (PHTS) Granted International Classification of Diseases (ICD) Code

The International Classification of Diseases Clinical Modification, revision 10, Clinical Modification system (ICD-10-CM) will now include PHTS. A unique code for PHTS (Q85.81) will be incorporated into the revision to be published on October 1, 2022. The code will improve patient care and facilitate future clinical, natural history and epidemiological research. CHELTENHAM, England–(BUSINESS WIRE)–PTEN Research … [Read more…]

Fort Lauderdale: AHF & Broward House to Open New Food Pantry

AHF’s Food For Health Program in partnership with Broward House are set to open a new food pantry in the Fort Lauderdale area Food Pantry Opening, Saturday, October 1st, 2022 – 9:00 a.m. – 12:00 p.m. FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF), the largest, non-profit global AIDS organization, in partnership with Broward House is … [Read more…]

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2022

NEW YORK–(BUSINESS WIRE)–Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group” or the “Company”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2022. “During the first half … [Read more…]